evidencegaps
Primary study · included by 1 review

Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study.

Zhao 2023 · Zhao Guangyin, Zhang Hongyu, Xu Fengkai, et al. · Translational lung cancer research · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Zhao 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.